Doliver Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,669
Closed -$259K 151
2019
Q2
$259K Buy
+6,669
New +$253K 0.1% 95
2018
Q2
Sell
-10,187
Closed -$357K 319
2018
Q1
$357K Buy
+10,187
New +$362K 0.16% 114
2017
Q1
Sell
-11,224
Closed -$356K 225
2016
Q4
$356K Sell
11,224
-39,873
-78% -$1.34M 0.3% 110
2016
Q3
$1.76M Buy
51,097
+36,922
+260% +$1.3M 1.49% 14
2016
Q2
$509K Buy
+14,175
New +$518K 0.43% 78
2015
Q4
Sell
-8,888
Closed -$334K 162
2015
Q3
$334K Buy
+8,888
New +$393K 0.25% 111

Other funds holding BME

Doliver Advisors's BME Position: Q3 2019 in Review

Doliver Advisors sold out of BlackRock Health Sciences Trust (BME) in Q3 2019, closing a stake of 6,669 shares — an estimated $259K sold.

Doliver Advisors first reported a position in BME in Q3 2015 and held it in 6 quarters. The position peaked at $1.76M in Q3 2016. 42 funds tracked by Wall St. Rank hold BME as of Q3 2019.

  • Doliver Advisors reported no remaining BlackRock Health Sciences Trust position as of Q3 2019 after selling out during the quarter.
  • Doliver Advisors sold 6,669 BlackRock Health Sciences Trust shares in Q3 2019, an estimated $259K.
  • Doliver Advisors first reported a position in BlackRock Health Sciences Trust in Q3 2015 and held it in 6 quarters.
  • Doliver Advisors's BlackRock Health Sciences Trust position peaked at $1.76M in Q3 2016.
  • 42 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2019.

Based on Doliver Advisors's 13F filing for Q3 2019, filed 4 Nov 2019.